ID

37573

Description

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention; ODM derived from: https://clinicaltrials.gov/show/NCT01830543

Lien

https://clinicaltrials.gov/show/NCT01830543

Mots-clés

Versions (1)
  1. 08/08/2019 08/08/2019 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

8 août 2019

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Atrial Fibrillation NCT01830543

Anglais

Eligibility Atrial Fibrillation NCT01830543

1 Formulaires  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
have a documented medical history of paroxysmal, persistent, or permanent non-valvular atrial fibrillation (af)
Description

Paroxysmal atrial fibrillation | Persistent atrial fibrillation | Permanent atrial fibrillation

Type de données

boolean

Alias
UMLS CUI [1]
C0235480
UMLS CUI [2]
C2585653
UMLS CUI [3]
C2586056
have undergone percutaneous coronary intervention (pci) procedure (with stent placement) for primary atherosclerotic disease
Description

Percutaneous Coronary Intervention Atherosclerosis | Placement of stent

Type de données

boolean

Alias
UMLS CUI [1,1]
C1532338
UMLS CUI [1,2]
C0004153
UMLS CUI [2]
C0522776
must have an international normalized ratio (inr) of 2.5 or below to be randomized
Description

International Normalized Ratio

Type de données

boolean

Alias
UMLS CUI [1]
C0525032
women must be postmenopausal before entry or practicing a highly effective method of birth control when heterosexually active
Description

Postmenopausal state | Gender Sexually active Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1]
C0232970
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0241028
UMLS CUI [2,3]
C0700589
be willing and able to adhere to the prohibitions and restrictions specified in the study protocol
Description

Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1]
C0525058
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
have any condition that contraindicates anticoagulant or antiplatelet therapy or would have an unacceptable risk of bleeding, such as, but not limited to: platelet count <90,000/microliter at screening, history of intracranial hemorrhage, 12 month history of clinically significant gastrointestinal bleeding, non-vka induced elevated prothrombin time (pt) at screening
Description

Condition Contraindicated Anticoagulant therapy | Condition Contraindicated Antiplatelet therapy | Bleeding risk Unacceptable | Platelet Count measurement | Intracranial Hemorrhage | Gastrointestinal Hemorrhage Disease length | Elevated prothrombin time Independent of Vitamin K Antagonist

Type de données

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C1444657
UMLS CUI [1,3]
C0150457
UMLS CUI [2,1]
C0348080
UMLS CUI [2,2]
C1444657
UMLS CUI [2,3]
C1096021
UMLS CUI [3,1]
C3251812
UMLS CUI [3,2]
C1883420
UMLS CUI [4]
C0032181
UMLS CUI [5]
C0151699
UMLS CUI [6,1]
C0017181
UMLS CUI [6,2]
C0872146
UMLS CUI [7,1]
C2674387
UMLS CUI [7,2]
C0332291
UMLS CUI [7,3]
C2267235
have anemia of unknown cause with a hemoglobin level <10 g/dl (<6.21 mmol/l)
Description

Anemia Cause Unknown | Hemoglobin measurement

Type de données

boolean

Alias
UMLS CUI [1,1]
C0002871
UMLS CUI [1,2]
C0015127
UMLS CUI [1,3]
C0439673
UMLS CUI [2]
C0518015
have a history of stroke or transient ischemic attack (tia)
Description

Cerebrovascular accident | Transient Ischemic Attack

Type de données

boolean

Alias
UMLS CUI [1]
C0038454
UMLS CUI [2]
C0007787
have a calculated creatinine clearance (crcl) <30 ml/min at screening
Description

Estimation of creatinine clearance by Cockcroft-Gault formula

Type de données

boolean

Alias
UMLS CUI [1]
C2711451
have known significant liver disease or liver function test (lft) abnormalities
Description

Liver disease | Liver function tests abnormal

Type de données

boolean

Alias
UMLS CUI [1]
C0023895
UMLS CUI [2]
C0151766
have any severe condition that would limit life expectancy to less than 12 months
Description

Condition Severe Limiting Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1,1]
C0348080
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0439801
UMLS CUI [1,4]
C0023671
Retour au début de la page

Similar models

Eligibility Atrial Fibrillation NCT01830543

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Paroxysmal atrial fibrillation | Persistent atrial fibrillation | Permanent atrial fibrillation
Item
have a documented medical history of paroxysmal, persistent, or permanent non-valvular atrial fibrillation (af)
boolean
C0235480 (UMLS CUI [1])
C2585653 (UMLS CUI [2])
C2586056 (UMLS CUI [3])
Percutaneous Coronary Intervention Atherosclerosis | Placement of stent
Item
have undergone percutaneous coronary intervention (pci) procedure (with stent placement) for primary atherosclerotic disease
boolean
C1532338 (UMLS CUI [1,1])
C0004153 (UMLS CUI [1,2])
C0522776 (UMLS CUI [2])
International Normalized Ratio
Item
must have an international normalized ratio (inr) of 2.5 or below to be randomized
boolean
C0525032 (UMLS CUI [1])
Postmenopausal state | Gender Sexually active Contraceptive methods
Item
women must be postmenopausal before entry or practicing a highly effective method of birth control when heterosexually active
boolean
C0232970 (UMLS CUI [1])
C0079399 (UMLS CUI [2,1])
C0241028 (UMLS CUI [2,2])
C0700589 (UMLS CUI [2,3])
Protocol Compliance
Item
be willing and able to adhere to the prohibitions and restrictions specified in the study protocol
boolean
C0525058 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Condition Contraindicated Anticoagulant therapy | Condition Contraindicated Antiplatelet therapy | Bleeding risk Unacceptable | Platelet Count measurement | Intracranial Hemorrhage | Gastrointestinal Hemorrhage Disease length | Elevated prothrombin time Independent of Vitamin K Antagonist
Item
have any condition that contraindicates anticoagulant or antiplatelet therapy or would have an unacceptable risk of bleeding, such as, but not limited to: platelet count <90,000/microliter at screening, history of intracranial hemorrhage, 12 month history of clinically significant gastrointestinal bleeding, non-vka induced elevated prothrombin time (pt) at screening
boolean
C0348080 (UMLS CUI [1,1])
C1444657 (UMLS CUI [1,2])
C0150457 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C1444657 (UMLS CUI [2,2])
C1096021 (UMLS CUI [2,3])
C3251812 (UMLS CUI [3,1])
C1883420 (UMLS CUI [3,2])
C0032181 (UMLS CUI [4])
C0151699 (UMLS CUI [5])
C0017181 (UMLS CUI [6,1])
C0872146 (UMLS CUI [6,2])
C2674387 (UMLS CUI [7,1])
C0332291 (UMLS CUI [7,2])
C2267235 (UMLS CUI [7,3])
Anemia Cause Unknown | Hemoglobin measurement
Item
have anemia of unknown cause with a hemoglobin level <10 g/dl (<6.21 mmol/l)
boolean
C0002871 (UMLS CUI [1,1])
C0015127 (UMLS CUI [1,2])
C0439673 (UMLS CUI [1,3])
C0518015 (UMLS CUI [2])
Cerebrovascular accident | Transient Ischemic Attack
Item
have a history of stroke or transient ischemic attack (tia)
boolean
C0038454 (UMLS CUI [1])
C0007787 (UMLS CUI [2])
Estimation of creatinine clearance by Cockcroft-Gault formula
Item
have a calculated creatinine clearance (crcl) <30 ml/min at screening
boolean
C2711451 (UMLS CUI [1])
Liver disease | Liver function tests abnormal
Item
have known significant liver disease or liver function test (lft) abnormalities
boolean
C0023895 (UMLS CUI [1])
C0151766 (UMLS CUI [2])
Condition Severe Limiting Life Expectancy
Item
have any severe condition that would limit life expectancy to less than 12 months
boolean
C0348080 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
C0023671 (UMLS CUI [1,4])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial